Denmark – Pharmaceutical products – Amgros 2027 1.705.a

Opportunity description

Amgros I/S (Amgros) is a partnership with the 5 regions as partners. Amgros wishes to enter into framework agreements for the medicinal products listed in the individual lots below, with a view to supplying the partners’ hospital pharmacies with medicinal products and possibly reselling them to the Faroe Islands and Greenland. Amgros resells the medicinal products to the hospital pharmacies at Amgros’ purchase price plus a surcharge. The framework agreements are non-exclusive. The framework agreements are entered into without any purchase obligation, and the hospital pharmacies in the regions are not obliged to use Amgros’ framework agreements. The tender number (lot) covers the following medicinal products: ATC Code: A04AA01 · Generic name: Ondansetron in pre-filled syringe · Pharmaceutical form: Solution for injection/infusion · Strength: 4 mg · Unit value: 16 mg · Quantity in units: 99. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A04AA01 · Generic name: Ondansetron in pre-filled syringe · Pharmaceutical form: Solution for injection/infusion · Strength: 8 mg · Unit value: 16 mg · Quantity in units: 99. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07BA01 · Generic name: Activated charcoal · Pharmaceutical form: Oral liquid · Strength: · Unit value: 5 g · Quantity in units: 56800. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EA06 · Generic name: Budesonide · Pharmaceutical form: Orodispersible tablets · Strength: 0,5 mg · Unit value: 9 mg · Quantity in units: 3660. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EA06 · Generic name: Budesonide · Pharmaceutical form: Orodispersible tablets · Strength: 1 mg · Unit value: 9 mg · Quantity in units: 167400. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EC02 · Generic name: Mesalazine · Pharmaceutical form: Gastro-resistant tablets · Strength: 400 mg · Unit value: 1,5 g · Quantity in units: 587. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EC02 · Generic name: Mesalazine · Pharmaceutical form: Gastro-resistant tablets · Strength: 500 mg · Unit value: 1,5 g · Quantity in units: 100. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EC02 · Generic name: Mesalazine · Pharmaceutical form: Gastro-resistant tablets · Strength: 800 mg · Unit value: 1,5 g · Quantity in units: 103040. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A07EC02 · Generic name: Mesalazine · Pharmaceutical form: Gastro-resistant tablets · Strength: 1000 mg · Unit value: 1,5 g · Quantity in units: 6333. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A16AB02 · Generic name: Imiglucerase · Pharmaceutical form: Powder for solution for infusion · Strength: 400 E · Unit value: 300 U · Quantity in units: 2251. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A16AB10 · Generic name: Velaglucerase alfa · Pharmaceutical form: Powder for solution for infusion · Strength: 400 E · Unit value: 300 U · Quantity in units: 808. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A16AX06 · Generic name: Miglustat · Pharmaceutical form: Capsules · Strength: 65 mg · Unit value: 0,3 g · Quantity in units: 343. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A16AX10 · Generic name: Eliglustat · Pharmaceutical form: Capsules · Strength: 84 mg · Unit value: 0,168 g · Quantity in units: 2240. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: A16AX15 · Generic name: Telotristat · Pharmaceutical form: Tablets · Strength: 250 mg · Unit value: 0,75 g · Quantity in units: 15780. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: B05XA03 · Generic name: Sodium chloride · Pharmaceutical form: Solution for infusion · Strength: 9 mg/ml · Package: 1500 ml · Unit value: 1000 ml · Quantity in units: 26001. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: B05XA03 · Generic name: Sodium chloride · Pharmaceutical form: Solution for infusion · Strength: 9 mg/ml · Package: 2000 ml · Unit value: 1000 ml · Quantity in units: 2784. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: L04AA03 · Generic name: Antilymphocyte immunoglobulin · Pharmaceutical form: Concentrate for solution for infusion · Strength: 50 mg/ml · Unit value: 1,05 g · Quantity in units: 215. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may therefore choose to submit a tender for one, several or all tender numbers, and awards are made separately for each individual tender number. A supplier may therefore be awarded one, several or all lots. Reference is made to the tender conditions, including those concerning the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for treating patients at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the tender conditions and the framework agreement. Procedure: open. Estimated value: 253,000,000 DKK. Review the original TED notice for the complete requirement, lots, amendments and attachments.